Opendata, web and dolomites

GOTBONE TERMINATED

Novel mechanisms of site-specific regulation of bone strength for the prevention of osteoporotic fractures: a translational project

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 GOTBONE project word cloud

Explore the words cloud of the GOTBONE project. It provides you a very rough idea of what is the project "GOTBONE" about.

cultures    background    special    site    determinants    notum    population    clinical    medicine    risk    lab    human    impaired    spectrum    health    osteoarthritis    complementary    biology    prevention    economic    genetically    sustain    vertebral    genetic    15    modified    rheumatology    locus    wnt16    professor    osteoporotic    2014    grem2    preclinical    cell    bone    regulates    mechanisms    drugs    3010    antagonist    fracture    dependent    microarchitecture    bmd    translational    interaction    least    excellence    thickness    collaborations    fragility    mineral    remaining    cortical    added    40    nature    representing    regulating    epidemiological    trabecular    skills    lipase    huge    predicts    supervisor    regulator    lifetime    protein    burden    volumetric    women    fellowship    wnt    biomarkers    assistant    reducing    murine    osteoporosis    academic    serum    translate    n    therapies    regulation    morphogenetic    mortality    performed    models    hip    men    prospective    basis    career    cohort    fractures    density   

Project "GOTBONE" data sheet

The following table provides information about the project.

Coordinator
GOETEBORGS UNIVERSITET 

Organization address
address: VASAPARKEN
city: GOETEBORG
postcode: 405 30
website: www.gu.se

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Sweden [SE]
 Project website https://gup.ub.gu.se/publication/269257
 Total cost 185˙857 €
 EC max contribution 185˙857 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2016
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2017
 Duration (year-month-day) from 2017-12-01   to  2019-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    GOETEBORGS UNIVERSITET SE (GOETEBORG) coordinator 185˙857.00

Map

 Project objective

Osteoporosis is a major health concern characterized by reduced bone mineral density (BMD) and impaired microarchitecture leading to increased risk of fractures and mortality, especially at the hip. At least 40% of women and 15% of men will sustain one or more fragility fractures in their remaining lifetime, representing a huge economic burden in Europe. Currently available osteoporosis drugs are effective in reducing vertebral fracture risk (dependent on trabecular bone) while less effective for non-vertebral and hip fracture risk (dependent on cortical bone). This proposal aims to identify novel mechanisms regulating site-specific fracture risk, on the basis of recent human genetic findings on the determinants of cortical bone thickness (WNT16 locus) and trabecular volumetric BMD (GREM2 locus). This translational research program will study the role of the WNT lipase NOTUM in the regulation of cortical bone thickness via its interaction with WNT16, a key regulator of cortical bone identified by the proposed supervisor (Nature Medicine 2014). We will next study how the Bone Morphogenetic Protein antagonist GREM2 regulates trabecular BMD. These studies will be performed using genetically modified murine models and human cell-cultures systems. Finally, in a prospective population-based cohort study (n=3010), we will test if serum level of NOTUM predicts the risk of fractures. Our long term goal is to translate these findings into novel biomarkers and more effective therapies for the prevention of osteoporotic fractures. The applicant is an Assistant Professor of Rheumatology with a special clinical focus on osteoporosis and a complementary preclinical research background in osteoarthritis but not osteoporosis. This fellowship in a lab of excellence in the field of translational osteoporosis research will enhance his skills in both bone biology and epidemiological studies and will provide a huge added-value to his academic career with a spectrum of new collaborations.

 Publications

year authors and title journal last update
List of publications.
2018 Thomas Funck-Brentano, Karin H Nilsson, Robert Brommage, Petra Henning, Ulf H Lerner, Antti Koskela, Juha Tuukkanen, Martine Cohen-Solal, Sofia Movérare-Skrtic, Claes Ohlsson
Porcupine inhibitors impair trabecular and cortical bone mass and strength in mice
published pages: 13-23, ISSN: 0022-0795, DOI: 10.1530/JOE-18-0153
Journal of Endocrinology 238/1 2019-06-11

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "GOTBONE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "GOTBONE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

MetEpiC (2020)

P53-dependent Metabolic and Epigenetic Reprogramming in Carcinogenesis

Read More  

PHOTOCARBOX (2020)

Increasing the scope of CO2-utilising photoreactions: asymmetric photosynthesis of amino acids

Read More  

pyrroQuin (2020)

Synthesis and Biological Evaluation of Pyrroquinoline Pseudo-Natural Products

Read More